Evidence-Based Insight: Clinical research links glutathione depletion with reduced immune cell proliferation and increased oxidative markers
Similar content being viewed by others Introduction Intervertebral disc degeneration (IDD) is a common chronic degenerative disease and the predominant contributing factor to low back pain (LBP) in aging individuals, which affects millions of people globally with mobility loss and quality of life decline, posing a severe socioeconomic and medical care burden 1,2,3
Though not FDA-approved for human use, animal research suggests remarkable healing properties including accelerated tendon and ligament repair, muscle tear healing, reduced inflammation at injury sites, improved gut health (beneficial for athletes with digestive issues), and potential neuroprotective effects
By engaging glucagon-like peptide-1 (GLP-1), glucagon (GCG), and glucose-dependent insulinotropic polypeptide (GIP) receptors simultaneously, the drug may modulate blood glucose levels and energy balance
Medication expiry dates represent the period during which manufacturers guarantee full potency, safety, and quality when stored correctly
We offer evidence based medicine that have been proven to increase longevity and quality of life
